Sunshine Biopharma Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $211.7K | $2.0M |
| FY2022 | — | $21.6M | $21.8M |
| FY2023 | — | $21.2M | $16.3M |
| FY2024 | — | $23.5M | $9.7M |
| FY2025 | — | $23.0M | $9.1M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $211.7K | $2.0M |
| FY2022 | — | $21.6M | $21.8M |
| FY2023 | — | $21.2M | $16.3M |
| FY2024 | — | $23.5M | $9.7M |
| FY2025 | — | $23.0M | $9.1M |